ArticleNature cancer2026

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study.

Anuradha Jayaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.